BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Osamu Matsui. Current Status of Hepatocellular Carcinoma Treatment in JapanClinical Drug Investigation 2012; 32(S2): 3 doi: 10.1007/BF03265492
2
Wen Chen, Tao Ma, Jian Zhang, Xiaozhen Zhang, Wei Chen, Yinan Shen, Xueli Bai, Tingbo Liang. A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinomaHPB 2020; 22(6): 795 doi: 10.1016/j.hpb.2019.12.013
3
Xiang Cheng, Ping Sun, Qing-Gang Hu, Zi-Fang Song, Jun Xiong, Qi-Chang Zheng. Transarterial (chemo)embolization for curative resection of hepatocellular carcinoma: a systematic review and meta-analysesJournal of Cancer Research and Clinical Oncology 2014; 140(7): 1159 doi: 10.1007/s00432-014-1677-4
4
Lin Mu, Julius Chapiro, Jeremiah Stringam, Jean-François Geschwind. Interventional Oncology in Hepatocellular CarcinomaThe Cancer Journal 2016; 22(6): 365 doi: 10.1097/PPO.0000000000000227
5
E. Jubeli, N. Yagoubi, F. Pascale, L. Bédouet, K. Slimani, D. Labarre, J.P. Saint-Maurice, A. Laurent, L. Moine. Embolization biomaterial reinforced with nanotechnology for an in-situ release of anti-angiogenic agent in the treatment of hyper-vascularized tumors and arteriovenous malformationsEuropean Journal of Pharmaceutics and Biopharmaceutics 2015; 96: 396 doi: 10.1016/j.ejpb.2015.09.006
6
Marcelo Guimaraes, Renan Uflacker. Locoregional Therapy for Hepatocellular CarcinomaClinics in Liver Disease 2011; 15(2): 395 doi: 10.1016/j.cld.2011.03.013
7
Alexander Gross, Thomas Albrecht. Transarterial Chemoembolisation (TACE) with Degradable Starch Microspheres (DSM) and Anthracycline in Patients with Locally Extensive Hepatocellular Carcinoma (HCC): Safety and EfficacyCardioVascular and Interventional Radiology 2020; 43(3): 402 doi: 10.1007/s00270-019-02364-w
8
Jianzhen Lin, Liangcai Wu, Xue Bai, Yuan Xie, Anqiang Wang, Haohai Zhang, Xiaobo Yang, Xueshuai Wan, Xin Lu, Xinting Sang, Haitao Zhao. Combination treatment including targeted therapy for advanced hepatocellular carcinomaOncotarget 2016; 7(43): 71036 doi: 10.18632/oncotarget.11954
9
James Ronald, Andrew B. Nixon, Daniele Marin, Rajan T. Gupta, Gemini Janas, Willa Chen, Paul V. Suhocki, Waleska Pabon-Ramos, David R. Sopko, Mark D. Starr, John C. Brady, Herbert I. Hurwitz, Charles Y. Kim. Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular CarcinomaRadiology 2017; 285(1): 311 doi: 10.1148/radiol.2017162555
10
Mario Petrillo, Francesca Patella, Filippo Pesapane, Matteo B Suter, Anna M Ierardi, Salvatore A Angileri, Chiara Floridi, Massimo de Filippo, Gianpaolo Carrafiello. Hypoxia and tumor angiogenesis in the era of hepatocellular carcinoma transarterial loco-regional treatmentsFuture Oncology 2018; 14(28): 2957 doi: 10.2217/fon-2017-0739
11
Huan Tong, Xiao Li, Chun Le Zhang, Jin Hang Gao, Shi Lei Wen, Zhi Yin Huang, Fu Qiang Wen, Ping Fu, Cheng Wei Tang. Transcatheter arterial embolization followed by octreotide and celecoxib synergistically prolongs survival of rabbits with hepatic VX2 allograftsJournal of Digestive Diseases 2013; 14(1): 29 doi: 10.1111/1751-2980.12001
12
Chen Zhou, Qi Yao, Hongsen Zhang, Xiaopeng Guo, Jiacheng Liu, Qin Shi, Songjiang Huang, Bin Xiong. Combining transcatheter arterial embolization with iodized oil containing Apatinib inhibits HCC growth and metastasisScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59746-1
13
Masatoshi Kudo. Future Treatment Option for Hepatocellular Carcinoma: A Focus on BrivanibDigestive Diseases 2011; 29(3): 316 doi: 10.1159/000327568
14
Mohamed Bouattour, Hélène Marijon, Chantal Dreyer, Sandrine Faivre, Éric Raymond. Thérapies ciblées dans le carcinome hépatocellulaireLa Presse Médicale 2010; 39(7-8): 753 doi: 10.1016/j.lpm.2009.11.016
15
Iliana Doycheva, Paul J. Thuluvath. Systemic Therapy for Advanced Hepatocellular Carcinoma: An Update of a Rapidly Evolving FieldJournal of Clinical and Experimental Hepatology 2019; 9(5): 588 doi: 10.1016/j.jceh.2019.07.012
16
Riccardo Lencioni, Josep M. Llovet, Guohong Han, Won Young Tak, Jiamei Yang, Alfredo Guglielmi, Seung Woon Paik, Maria Reig, Do Young Kim, Gar-Yang Chau, Angelo Luca, Luis Ruiz del Arbol, Marie-Aude Leberre, Woody Niu, Kate Nicholson, Gerold Meinhardt, Jordi Bruix. Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trialJournal of Hepatology 2016; 64(5): 1090 doi: 10.1016/j.jhep.2016.01.012
17
Sebastian Buschauer, Andreas Koch, Philipp Wiggermann, Martina M�ller, Claus Hellerbrand. Hepatocellular carcinoma cells surviving doxorubicin treatment exhibit increased migratory potential and resistance to doxorubicin re-treatment in�vitroOncology Letters 2018;  doi: 10.3892/ol.2018.7887
18
Yanming Zhou, Xiaofeng Zhang, Lupeng Wu, Feng Ye, Xu Su, Lehua Shi, Bin Li. Meta-analysis: preoperative transcatheter arterial chemoembolization does not improve prognosis of patients with resectable hepatocellular carcinomaBMC Gastroenterology 2013; 13(1) doi: 10.1186/1471-230X-13-51
19
Osamu Matsui. Current Status of Hepatocellular Carcinoma Treatment in JapanClinical Drug Investigation 2012; 32: 3 doi: 10.2165/1163021-S0-000000000-00000
20
Minoru Matsubara, Hidenori Shiraha, Jyunro Kataoka, Masaya Iwamuro, Shigeru Horiguchi, Shin-ichi Nishina, Nobuyuki Takaoka, Masayuki Uemura, Akinobu Takaki, Shinichiro Nakamura, Yoshiyuki Kobayashi, Kazuhiro Nouso, Kazuhide Yamamoto. Des-γ-carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinomaJournal of Gastroenterology and Hepatology 2012; 27(10): 1602 doi: 10.1111/j.1440-1746.2012.07173.x
21
Manon Buijs, Diane K. Reyes, Timothy M. Pawlik, Amanda L. Blackford, Riad Salem, Wells A. Messersmith, Colin D. Weekes, Mary Mulcahy, Ihab R. Kamel, Jean-Francois H. Geschwind. Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinomaCancer 2013; 119(5): 1042 doi: 10.1002/cncr.27859
22
C. Damiano Gadaleta, Girolamo Ranieri. Trans-arterial chemoembolization as a therapy for liver tumours: New clinical developments and suggestions for combination with angiogenesis inhibitorsCritical Reviews in Oncology/Hematology 2011; 80(1): 40 doi: 10.1016/j.critrevonc.2010.10.005